Travere Therapeutics Inc (TVTX) — Cash Flow Reinvestment Rate
Travere Therapeutics Inc (TVTX) has a Cash Flow Reinvestment Rate of 1.42x as of December 2025, reinvesting $85.88 Million (capex $375.00K plus investments $-85.50 Million) from operating cash flow of $60.68 Million. Check TVTX cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Travere Therapeutics Inc Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for Travere Therapeutics Inc across 2 annual periods. Explore Travere Therapeutics Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Travere Therapeutics Inc (2017–2025)
Year-by-year capital reinvestment analysis for Travere Therapeutics Inc. For live market cap and broader valuation context, see market value of Travere Therapeutics Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.83x | $144.61 Million | $37.78 Million | $58.16 Million | ▲ +8.5% |
| 2017 | 3.53x | $26.12 Million | $7.40 Million | $14.01 Million | — |